logologo
QuantliQuantli

Claritev Corp

CTEV

NYSE

Health Care

$32.59

USD

+5.75 (+21.42%)

At close: Aug 7, 2026, 4:00 PM EDT

Market Cap $445.46M

Volume 330.0K

Price (USD)
Price (USD)

About Claritev Corp

Claritev Corp. engages in providing data analytics and technology-enabled solutions. The company is headquartered in Mclean, Virginia and currently employs 3,000 full-time employees. The company went IPO on 2020-02-10. The Company’s services include analytics-based services, data & decision science services, network-based services, payment and revenue integrity, end-to-end surprise billing service, and Claritev payments. The firm uses its analytics-based services to price surprise bills and leverages reimbursement data from millions of claims repriced through these services and accepted by providers to assist in negotiations and calculate offers for arbitration when necessary. The company uses its payment integrity services on its network claims. The Company’s payment integrity offers advanced code editing, clinical negotiation, itemized bill review, coordination of benefits, subrogation, data mining, Medicare secondary payer validation, and end stage renal disease validation. The company provides solutions for the commercial market, government healthcare plans, and property and casualty healthcare payors.

HQ

McLean, VIRGINIA, US

Founded

2020

Employees

3,000

Quantli Score

8.4

Outperform

Fin. Health

8.1

Profitability

7.6

Growth

9.0

Cash-Flow Q.

8.8

Key Metrics

4 metrics our research team weighs before forming a view on CTEV.

Based on Quantli research · SEC filings · as of Q1 2026

METRIC

VALUE

CHANGE

TREND (3Y)

Gross Margin (TTM)

73.2%

Operating Margin (TTM)

4.3%

Net Margin (TTM)

-29.3%

Free Cash Flow (TTM)

$-35.90M

Financial Snapshot

Full Financials

Revenue

$978.76M

YoY

Gross Margin

73%

TTM

YoY

Net Income

$-286.52M

YoY

Operating Cash Flow

$101.60M

YoY

Key Statistics

Open

$29.14

Previous Close

$26.84

Day Range

$29.14 - $38.99

52 Week Range

$11.50 - $74.07

Volume

330.0K

Average Volume (10 Days)

80.0K

Dividend Yield

Valuation Measurement

Market Cap

$445.46M

P/E Ratio (TTM)

P/S Ratio (TTM)

0.46

Financial Highlights

Profit Margin

-29.3%

Return on Assets

-5.9%

Return on Equity

122.2%

Revenue (TTM)

$978.76M

Net Income (TTM)

$-286.52M

Diluted EPS (TTM)

-$17.33

Total Cash (MRQ)

$21.33M

Levered FCF (TTM)

$-35.90M

Turn research into action

Knowing a stock is strong is the start. Knowing how to invest in it when you spot good research is good returns.

Swing Strategy

Buy support, sell on recovery.

Best for:

Risk-tolerant

Position Strategy

Ride market cycles. Patient hold.

Best for:

Patient investors

Trend Following

Enter on trend. Cut losses fast.

Best for:

Active traders

Go deeper on CTEV

Similar Stocks

VEEV

Veeva Systems Inc

$230.47

+5.8%

AMWL

American Well Corp

$13.52

+4.6%

EVH

Evolent Health Inc

$3.95

+10.0%

PHR

Phreesia Inc

$12.51

+9.5%

Earnings Calendar

Next Earnings

Estimated Q3 Release

Nov 05

Est. EPS

Adjusted consensus estimate

-$4.02

Analyst Consensus

Buy

Based on 1 analyst ratings

Avg Target: $32.00

(-1.8% upside)

High: $32.00 · Low: $32.00

Strong Buy

0%

Buy

100%

Hold

0%

Sell

0%

Strong Sell

0%

View full analyst ratings